Ikonisys

Business Services · Connecticut, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

5 Science Park, New Haven, Connecticut, ...

Phone Number

(203) 776-0791

Revenue

<$5 Million

Stock Symbol

ALIKO

Industry

Business Services Manufacturing Healthcare Services Research & Development Medical Devices & Equipment Medical Laboratories & Imaging Centers

About Ikonisys

Ikonisys SA is a cell-based diagnostics company based in Paris (France), New Haven (Connecticut, USA) and Milan (Italy) specialized in the early and accurate detection of cancer. The company develops, produces and markets the proprietary Ikoniscope20® platform, a fully-automated solution designed to deliver accurate and reliable detection and analysis of rare cells. Ikonisys has received FDA clearance for several automated diagnostic applications, which are also marketed in Europe under CE certification. Through its breakthrough fluorescence microscopy platform, the company continues to develop a stream of new tests, including liquid biopsy tests based on Circulating Tumor Cells (CTC).Explore more
Ikonisys's Social MediaSIC Code 38,382NAICS Code 33,334Ticker EPA: ALIKOShow more

Ikonisys Org Chart

PhoneEmail
MK
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
TN
United States flag for contact location.

Senior Customer Support Engineer & Supervisor

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Ikonisys

Compare insights from companies similar to Ikonisys, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Ikonisys

<$5M
1-10
Public
$56.4M
1999
MK
Michael KilpatrickChief Scientific Officer
$16.4M
11-50
Private
<$5M
2008
DS
Dale SadlikCo-CEO & Executive Director
$7.3M
11-50
Private
$19.1M
2009
CN
Cindy NauraisSenior Manager, Strategy & Operations
<$5M
11-50
Private
$19.4M
2014
JA
Jenna AbelliPresident & CEO
<$5M
11-50
Private
<$5M
1998
<$5M
1-10
Private
-
1989
JS
Julia SoneiraVice President
<$5M
1-10
Private
<$5M
2009
N/A
Illustration of an envelope

Ikonisys Tech Stack

A closer look at the technologies used by Ikonisys

Top Business Services Companies

Frequently Asked Questions Regarding Ikonisys

What is Ikonisys's stock symbol?
Ikonisys's stock symbol is ALIKO
What is Ikonisys's official website?
Ikonisys's official website is www.ikonisys.com
What is Ikonisys's Revenue?
Ikonisys's revenue is <$5 Million
What is Ikonisys's SIC code?
Ikonisys's SIC: 38,382
What is Ikonisys's NAICS code?
Ikonisys's NAICS: 33,334
How many employees does Ikonisys have?
Ikonisys has 1-10 employees
What industry does Ikonisys belong to?
Ikonisys is in the industry of: Business Services, Manufacturing, Healthcare Services
What is Ikonisys competition?
Ikonisys top competitors include: Bruin Biometrics, Sofregen Medical, DisplayMate Technologies, PneumaCare
What companies has Ikonisys acquired?
Ikonisys has acquired the companies: Hospitex Diagnostics
What technology does Ikonisys use?
Some of the popular technologies that Ikonisys uses are: WooCommerce, WordPress.org, PHP, RackSpace Cloud DNS
How do I contact Ikonisys?
Ikonisys contact info: Phone number: (203) 776-0791 Website: www.ikonisys.com
What does Ikonisys do?

Ikonisys SA is a cell-based diagnostics company based in Paris (France), New Haven (Connecticut, USA) and Milan (Italy) specialized in the early and accurate detection of cancer. The company develops, produces and markets the proprietary Ikoniscope20® platform, a fully-automated solution designed to deliver accurate and reliable detection and analy... sis of rare cells. Ikonisys has received FDA clearance for several automated diagnostic applications, which are also marketed in Europe under CE certification. Through its breakthrough fluorescence microscopy platform, the company continues to develop a stream of new tests, including liquid biopsy tests based on Circulating Tumor Cells (CTC).Read More

What are Ikonisys social media links?
Ikonisys Linkedin page Ikonisys Twitter page
Who invested in Ikonisys?
Ikonisys has 18 investors including Trevi Health Ventures, Lakeview Capital Management, Trevi Health Ventures and New Science Ventures.
Is Ikonisys a public company?
Yes, Ikonisys is a public company and is traded under the symbol ALIKO
See more information about Ikonisys

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.